1
|
Gauna F, Carof S, Mouret-Fourme E, Coupier I, Mari V, Moretta-Serra J, Mancini J, Noguès C, Bouhnik AD. Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants. J Genet Couns 2024; 33:370-381. [PMID: 37282361 DOI: 10.1002/jgc4.1734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 05/17/2023] [Accepted: 05/21/2023] [Indexed: 06/08/2023]
Abstract
Understanding how gender norms affect parents' communication of genetic and cancer risk information to their children can enable healthcare professionals to better facilitate cascade genetic testing. We conducted a qualitative study with semi-structured interviews to determine social factors associated with parents carrying the BRCA1/2 pathogenic variants who communicated cancer prevention practices to their children. Thirty adult carriers (23 women, 7 men) participated in the interviews. All had at least one child aged over 8 years old. Interview topics included their discovery of the variants, their relationship to their body and to the risk of cancer, as well as disclosure to and subsequent communication with their children after testing positive for BRCA1/2. The interviews were analyzed qualitatively, and the major themes identified were identified and compared. We described the roles played by the BRCA1/2 carriers and their partners in communicating cancer prevention practices to their children, from how they managed their own risk of cancer after testing positive, to how they disclosed the risks linked to these pathogenic variants to their children. We also described their involvement in the process of their children going for professional genetic consultation. Gender norms lead women to be more attentive than men to their own health and that of their loved ones. In the context of the transmission of genetic information to children, gender differences in behavior are reinforced by perceptions of the risks of BRCA1/2 variants and women's related health management practices. Cancer prevention is shaped by complex links between gender norms and health management practices.
Collapse
Affiliation(s)
- F Gauna
- Aix-Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - S Carof
- Sorbonne Université, GEMASS (CNRS, Sorbonne Université), Paris, France
| | | | - I Coupier
- Gastroenterology and Genetic Department, Montpellier Hospital, Montpellier, France
| | - V Mari
- Unité d'Oncogénétique, Centre Antoine Lacassagne, Nice, France
| | - J Moretta-Serra
- Institut Paoli Calmette, Departement d'Anticipation et de Suivi du Cancer, Pôle Clinique Consultations d'Oncologie Genétique, Marseille, France
| | - J Mancini
- Aix-Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
- AP-HM, BIOSTIC, Hop Timone, Marseille, France
| | - C Noguès
- Aix-Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
- Institut Paoli Calmette, Departement d'Anticipation et de Suivi du Cancer, Pôle Clinique Consultations d'Oncologie Genétique, Marseille, France
| | - A D Bouhnik
- Aix-Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| |
Collapse
|
2
|
Bourmaud A, Fianu A, Kervran C, Verga-Gérard A, Fournel I, Dumas A, Mancini J, Alla F, Omorou A, Giraudeau B. Corrigendum de l'article « Version française des recommandations de la déclaration d'Ottawa sur la conception et la conduite éthique d'essais randomisés en clusters, dans le contexte législatif français » [RESPE 71 (2023) 101847]. Rev Epidemiol Sante Publique 2023; 71:102188. [PMID: 37939627 DOI: 10.1016/j.respe.2023.102188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2023] Open
Affiliation(s)
- A Bourmaud
- Unité d'épidémiologie clinique, CIC-EC 1426, Hôpital Universitaire Robert Debré, AP-HP, Paris et Université Paris-Cité, Paris, France.
| | - A Fianu
- Inserm CIC1410, CHU Réunion, Saint-Pierre, France/CERPOP, Université de Toulouse, Inserm, UPS, Toulouse, France
| | - C Kervran
- Equipe MeRISP, Inserm UMR U1219, Bordeaux Population Health Research Center (BPH), Université de Bordeaux, Bordeaux, France
| | - A Verga-Gérard
- CIC-EC 1433, Nancy, Inserm ; RECaP/ F-CRIN, Nancy, France
| | - I Fournel
- CHU Dijon Bourgogne, Inserm, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, F21000 Dijon, France
| | - A Dumas
- Université Paris-Cité, ECEVE UMR 1123, Inserm, Paris, France
| | - J Mancini
- Aix Marseille Université, AP-HM, Inserm, IRD, ISSPAM, SESSTIM, BioSTIC, Marseille, France
| | - F Alla
- Université de Bordeaux, Inserm U1218, Bordeaux 33000, France ; Prevention Department, Centre hospitalier universitaire de Bordeaux, France
| | - A Omorou
- CHRU-Nancy, Inserm, Université de Lorraine, CIC, Epidémiologie clinique, F-54000 Nancy, France
| | - B Giraudeau
- Université de Tours, Université de Nantes, Inserm, SPHERE U1246, Tours, France ; INSERM CIC1415, CHRU de Tours, Tours, France
| |
Collapse
|
3
|
Bourmaud A, Fianu A, Kervan C, Verga-Gérard A, Fournel I, Dumas A, Mancini J, Alla F, Omorou A, Giraudeau B. [French version of The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials, in a French law context]. Rev Epidemiol Sante Publique 2023; 71:101847. [PMID: 37167813 DOI: 10.1016/j.respe.2023.101847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 01/06/2023] [Accepted: 03/27/2023] [Indexed: 05/13/2023] Open
Abstract
INTRODUCTION There is growing evidence on the ethical challenges raised by cluster randomized trials. This specificity is not reflected in the legal texts regulating research, which creates difficulties for researchers implementing these experimental designs. The Ottawa Statement (Weijer et al. 2012) aims to provide detailed guidance on the ethical design, conduct and assessment of cluster trials. More broadly aims to help research stakeholders and decision-makers to make informed ethical decisions regarding the particularity of these experimental designs. It seems that this international statement, written in English, is not sufficiently accessible to all of the French professionals involved in health research. The aim of this article is to provide these professionals with a contextualized and illustrated French translation of the "Ottawa statement". METHOD . The "complex design" working group of the RECaP network (Research in Clinical Epidemiology and Public Health), carried out this work. A first version was discussed by the authors in several meetings. It was completed by contextual explanations and examples of French studies currently conducted by the authors. The final version was obtained by consensus and validated by the group. RESULTS . This work reports 15 recommendations grouped into 7 key questions: How to justify cluster design? How to submit an article to an ethics committee? How to identify research participants? How and when to obtain informed consent? Who are the gatekeepers? How to assess benefits and harm? How to protect vulnerable participants? Each of these recommendations is specific to cluster trials. The recommendations are explained and detailed through concrete examples. CONCLUSION Without interfering with current French laws, this work provides a framework for the organization, conduct and ethical assessment of cluster randomized trials in France. In the present-day context, it is essential that all concerned groups can base their decisions on recommendations in line with the elementary principles of health research ethics.
Collapse
Affiliation(s)
- A Bourmaud
- Unité d'épidémiologie clinique, CIC-EC 1426, Hôpital Universitaire Robert Debré, AP-HP, Paris et Université Paris-Cité, Paris, France.
| | - A Fianu
- Inserm CIC1410, CHU Réunion, Saint-Pierre, France/CERPOP, Université de Toulouse, Inserm, UPS, Toulouse, France
| | - C Kervan
- Equipe MeRISP, Inserm UMR U1219, Bordeaux Population Health Research Center (BPH), Université de Bordeaux, Bordeaux, France
| | - A Verga-Gérard
- CIC-EC 1433, Nancy, Inserm ; RECaP/ F-CRIN, Nancy, France
| | - I Fournel
- CHU Dijon Bourgogne, Inserm, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, F21000 Dijon, France
| | - A Dumas
- Université Paris-Cité, ECEVE UMR 1123, Inserm, Paris, France
| | - J Mancini
- Aix Marseille Université, AP-HM, Inserm, IRD, ISSPAM, SESSTIM, BioSTIC, Marseille, France
| | - F Alla
- Université de Bordeaux, Inserm U1218, Bordeaux 33000, France; Prevention Department, Centre hospitalier universitaire de Bordeaux, France
| | - A Omorou
- CHRU-Nancy, Inserm, Université de Lorraine, CIC, Epidémiologie clinique, F-54000 Nancy, France
| | - B Giraudeau
- Université de Tours, Université de Nantes, Inserm, SPHERE U1246, Tours, France; INSERM CIC1415, CHRU de Tours, Tours, France
| |
Collapse
|
4
|
Buono-Michel C, Mancini J, Planta M, Agostini A, Carcopino X. [Outcome of women younger than 30 years of age followed for untreated high-grade cervical intraepithelial lesion]. Gynecol Obstet Fertil Senol 2022; 50:610-614. [PMID: 35513265 DOI: 10.1016/j.gofs.2022.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 04/05/2022] [Accepted: 04/19/2022] [Indexed: 06/14/2023]
Abstract
OBJECTIVES To assess the probability of spontaneous regression of high grade cervical intraepithelial neoplasia (HGCIN) in women under 30 and the predictive factors for such evolution. METHODS We conducted a bicentric retrospective study. A total of 98 patients under 30 and with untreated HGCIN were included from 01/01/2010 to 31/12/2019. For each patient, the initial clinical and colposcopic characteristics were systematically documented. In compliance with French guidelines, these patients were offered repeated 6-months colposcopic follow-up for 2years. The endpoint was the occurrence of spontaneous regression of the HGCIN defined by normalization of colposcopy, and/or a negative biopsy and/or a negative HPV test or histological regression to low grade CIN, or a colposcopy showing simple minor abnormalities requiring no biopsy. RESULTS Spontaneous HGCIN regression was observed in 37/98 patients. The median follow-up was of 16 (10.5-24.3) months. Predictive factors for spontaneous regression were: minor initial cytological abnormalities (HR=3.4; 95% CI: 1.02-11.05) and grade 1 atypical transformation at initial colposcopy (TAG1) (HR=2.3; 95% CI: 1.1-4.7). CONCLUSION Before 30, the probability of spontaneous regression of HGCIN exists but remains low. Predictive factors for such evolution are minor initial cytological abnormalities and TAG1 colposcopic impression.
Collapse
Affiliation(s)
- C Buono-Michel
- Service de gynécologie-obstétrique, hôpital Nord, chemin des Bourrely, 13915 Marseille cedex 20, France
| | - J Mancini
- Aix-Marseille université, INSERM, IRD, AP-HM, UMR1252, SESSTIM, department of public health (BIOSTIC), hôpital de la Timone, Marseille, France; Département de santé publique, hôpital de la Timone, 264, rue Saint-Pierre, 13395 Marseille cedex 5, France
| | - M Planta
- Aix-Marseille université, INSERM, IRD, AP-HM, UMR1252, SESSTIM, department of public health (BIOSTIC), hôpital de la Timone, Marseille, France; Département de santé publique, hôpital de la Timone, 264, rue Saint-Pierre, 13395 Marseille cedex 5, France
| | - A Agostini
- Service de gynécologie-obstétrique, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France
| | - X Carcopino
- Department of obstetrics and gynaecology, hôpital Nord, AP-HM, Aix-Marseille university (AMU), université Avignon, CNRS, IRD, IMBE UMR 7263, 13397 Marseille, France; Service de gynécologie-obstétrique, hôpital Nord, chemin des Bourrely, 13915 Marseille cedex 20, France.
| |
Collapse
|
5
|
Cheung W, Samimi S, Kassam S, Colwell B, Meyer P, Knight G, Ma K, Eberg M, Mancini J, Alemayehu M, Martinez D, Packalen M, Wani R, Ngan E, Du Y, Inam N. P-28 Real-world observational study of MVASI in metastatic colorectal cancer patients in Canada: Baseline patient characteristics. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
6
|
Bendiane M, Rey D, Richard Tallet A, Mancini J. 76P How to explain current reluctance against therapeutic de-escalation: Results of the exploratory qualitative phase of the mixed method research program CARTE therapy in older women with early breast cancer in France. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.03.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
7
|
Rique A, Martel H, Piazzai C, Mancini J, Gravier R, Arregle F, Dernys A, Gardenat A, Casalta AC, Renard S, Hubert S, N'guyen K, Habib G. Ejection fraction basal strain ratio (EFBSR), a new accurate echocardiographic deformation parameter to screen cardiac amyloidosis among hypertrophic cardiopathies. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Early diagnosis of cardiac amyloidosis (CA) is challenging. Several echocardiographic (echo) parameters have been proposed to differentiate CA from hypertrophic cardiomyopathy (HCM), but their respective value is debated. CA is known to be characterized by a more severe decline in longitudinal deformation parameters as compared with radial function parameters (LVEF). This characteristic justified the use of the ejection fraction strain ratio (EFSR) in these patients. However, since longitudinal dysfunction usually predominates in basal segments (apical sparing), we postulated that a new parameter focusing on LVEF and basal LV deformation (EFBSR: ejection fraction basal strain ratio) will even better discriminate patients with CA from HCM than EFSR and other echo or strain parameters.
Purpose
To compare the accuracy of deformation-based echocardiographic parameters for detecting CA in a population with different causes of LV hypertrophy.
Methods and results
We included 237 subjects, of which 89 patients with CA (77±10.7 years, 72% male, EF: 56.2±12.8%, and mean interventricular septum: 18.3±3.5 mm), 137 patients with hypertrophic cardiomyopathies (HCM), 52 patients with severe aortic stenosis with myocardial remodeling, 20 patients with arterial hypertension, and 20 control patients. Conventional echocardiographic parameters and strain-derived ratios (Relative apical sparing (RELAPS), Ejection Fraction Strain Ratio (EFSR) and EFBSR) were analyzed.
EFBSR and RELAPS presented with the best performance to discriminate CA from other causes of hypertrophy (Area Under the Curve (AUC): 0.880; 95% CI: 0.830–0.929 and 0.903; 95% CI: 0.863–0.943 respectively) (p-value=0.3). In our study, among all the parameters, RELAPS had the best specificity (89.8% vs 88.3% for EFBSR), whereas EFBSR had the best sensitivity (78.7% vs 76.4% for RELAPS). EFBSR ranged from 35.25 to 1.83 and the cutoff value to differentiate CA from other hypertrophic cardiopathy was an EFBSR >7.75.
Conclusions
Our study demonstrates that in patients with LV hypertrophy, a new deformation parameter, the ejection fraction basal strain ratio (EFBSR) can accurately differentiate CA from other causes of myocardial thickening and can be used in routine practice for screening.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Rique
- APHM La Timone Hospital, Marseille, France
| | - H Martel
- APHM La Timone Hospital, Marseille, France
| | - C Piazzai
- APHM La Timone Hospital, Marseille, France
| | - J Mancini
- APHM La Timone Hospital, Marseille, France
| | - R Gravier
- APHM La Timone Hospital, Marseille, France
| | - F Arregle
- APHM La Timone Hospital, Marseille, France
| | - A Dernys
- APHM La Timone Hospital, Marseille, France
| | - A Gardenat
- APHM La Timone Hospital, Marseille, France
| | | | - S Renard
- APHM La Timone Hospital, Marseille, France
| | - S Hubert
- APHM La Timone Hospital, Marseille, France
| | - K N'guyen
- APHM La Timone Hospital, Marseille, France
| | - G Habib
- APHM La Timone Hospital, Marseille, France
| |
Collapse
|
8
|
Testa D, Jourde-Chiche N, Mancini J, Varriale P, Morisseau V, Radoszycki L, Chiche L. Analyse en clusters non supervisée des données en vie réelle d’une communauté en ligne de patients lupiques pour identifier des profils concernant leurs préférences thérapeutiques. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
9
|
Memoli V, Rey D, Lauzier S, Mancini J, Bouhnik AD. 47P The impact of endocrine therapy and chemotherapy on quality of life 5 years after a breast cancer diagnosis: VICAN5 survey. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.03.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
10
|
Ciccolella M, Andreone S, Mancini J, Sestili P, Negri D, Pacca AM, D’Urso MT, Macchia D, Canese R, Pang K, SaiYing Ko T, Decadt Y, Schiavoni G, Mattei F, Belardelli F, Aricò E, Bracci L. Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models. Cells 2021; 10:845. [PMID: 33917958 PMCID: PMC8068355 DOI: 10.3390/cells10040845] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Revised: 03/31/2021] [Accepted: 04/01/2021] [Indexed: 02/06/2023] Open
Abstract
Salivary gland tumors are a heterogeneous group of neoplasms representing less than 10% of all head and neck tumors. Among salivary gland tumors, salivary duct carcinoma (SDC) is a rare, but highly aggressive malignant tumor resembling ductal breast carcinoma. Sublingual treatments are promising for SDC due to the induction of both local and systemic biological effects and to reduced systemic toxicity compared to other administration routes. In the present study, we first established that the sublingual administration of type I IFN (IFN-I) is safe and feasible, and exerts antitumor effects both as monotherapy and in combination with chemotherapy in transplantable tumor models, i.e., B16-OVA melanoma and EG.7-OVA lymphoma. Subsequently, we proved that sublingual IFN-I in combination with cyclophosphamide (CTX) induces a long-lasting reduction of tumor mass in NeuT transgenic mice that spontaneously develop SDC. Most importantly, tumor shrinkage in NeuT transgenic micewas accompanied by the emergence of tumor-specific cellular immune responses both in the blood and in the tumor tissue. Altogether, these results provide evidence that sublingual IFN holds promise in combination with chemotherapy for the treatment of cancer.
Collapse
Affiliation(s)
- Maria Ciccolella
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| | - Sara Andreone
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| | - Jacopo Mancini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| | - Paola Sestili
- National Center for the Control and Evaluation of Medicines, 00161 Rome, Italy;
| | - Donatella Negri
- Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | - Anna Maria Pacca
- Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy; (A.M.P.); (M.T.D.); (D.M.)
| | - Maria Teresa D’Urso
- Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy; (A.M.P.); (M.T.D.); (D.M.)
| | - Daniele Macchia
- Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy; (A.M.P.); (M.T.D.); (D.M.)
| | - Rossella Canese
- Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | - Ken Pang
- Biolingus AG, CH-6052 Hergiswil NW, Switzerland; (K.P.); (T.S.K.); (Y.D.)
- Murdoch Children’s Research Institute, Parkville 3052, Australia
- The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia
- Department of Paediatrics, University of Melbourne, Parkville 3010, Australia
| | - Thomas SaiYing Ko
- Biolingus AG, CH-6052 Hergiswil NW, Switzerland; (K.P.); (T.S.K.); (Y.D.)
| | - Yves Decadt
- Biolingus AG, CH-6052 Hergiswil NW, Switzerland; (K.P.); (T.S.K.); (Y.D.)
| | - Giovanna Schiavoni
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| | - Fabrizio Mattei
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| | - Filippo Belardelli
- Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, 00133 Rome, Italy;
| | - Eleonora Aricò
- Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | - Laura Bracci
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (M.C.); (S.A.); (J.M.); (G.S.); (F.M.)
| |
Collapse
|
11
|
Andreone S, Gambardella AR, Mancini J, Loffredo S, Marcella S, La Sorsa V, Varricchi G, Schiavoni G, Mattei F. Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight. Front Immunol 2020; 11:571593. [PMID: 33329534 PMCID: PMC7734277 DOI: 10.3389/fimmu.2020.571593] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 10/28/2020] [Indexed: 02/06/2023] Open
Abstract
Interleukin-33 (IL-33) is an epithelial-derived cytokine that can be released upon tissue damage, stress, or infection, acting as an alarmin for the immune system. IL-33 has long been studied in the context of Th2-related immunopathologies, such as allergic diseases and parasitic infections. However, its capacity to stimulate also Th1-type of immune responses is now well established. IL-33 binds to its specific receptor ST2 expressed by most immune cell populations, modulating a variety of responses. In cancer immunity, IL-33 can display both pro-tumoral and anti-tumoral functions, depending on the specific microenvironment. Recent findings indicate that IL-33 can effectively stimulate immune effector cells (NK and CD8+ T cells), eosinophils, basophils and type 2 innate lymphoid cells (ILC2) promoting direct and indirect anti-tumoral activities. In this review, we summarize the most recent advances on anti-tumor immune mechanisms operated by IL-33, including the modulation of immune checkpoint molecules, with the aim to understand its potential as a therapeutic target in cancer.
Collapse
Affiliation(s)
- Sara Andreone
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| | | | - Jacopo Mancini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| | - Stefania Loffredo
- Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.,Institute of Experimental Endocrinology and Oncology "G. Salvatore", National Research Council (CNR), Naples, Italy
| | - Simone Marcella
- Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy
| | - Valentina La Sorsa
- Research Coordination and Support Service, CoRI, Istituto Superiore di Sanità, Rome, Italy
| | - Gilda Varricchi
- Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.,Institute of Experimental Endocrinology and Oncology "G. Salvatore", National Research Council (CNR), Naples, Italy
| | - Giovanna Schiavoni
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| | - Fabrizio Mattei
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
12
|
Mace P, Mancini J, Gorincour G, Quarello E. Accuracy of qualitative and quantitative cranial ultrasonographic markers in first-trimester screening for open spina bifida and other posterior brain defects: a systematic review and meta-analysis. BJOG 2020; 128:354-365. [PMID: 32966672 DOI: 10.1111/1471-0528.16530] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/14/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND The significant number of qualitative and quantitative ultrasound markers described for first-trimester screening of open spina bifida (OSB) and other posterior brain defects (oPBD) has resulted in their complex implementation and interpretation for a widespread screening and in a lack of consensus regarding diagnostic accuracy. OBJECTIVES To assess and compare the accuracy of qualitative and quantitative cranial sonographic markers at 11-14 weeks of gestation for the detection of OSB and oPBD. SEARCH STRATEGY A systematic literature search was performed in MEDLINE and COCHRANE from 2009 to April 2020. SELECTION CRITERIA Studies assessing the diagnostic accuracy of quantitative and/or qualitative ultrasound signs to predict OSB and oPBD were included. Cohort studies and case-control studies were also considered. DATA COLLECTION AND ANALYSIS Two reviewers independently extracted data and assessed the risk of bias. The overall pooled estimate and a summary receiver operating characteristic curve was estimated for each subgroup (qualitative and quantitative assessment). MAIN RESULTS Twenty-three studies were included in our meta-analysis. The pooled sensitivity and specificity for qualitative assessment were 76.5% and 99.6%, and for quantitative assessment were 84.5% and 96.3%, respectively; specificity for the qualitative ultrasound signs was significantly higher (P = 0.001). The overall sensitivity of cranial sonographic markers for the screening of oPBD was 76.7% and specificity was 97.5%. CONCLUSIONS The qualitative approach demonstrated greater specificity, so this would appear to be more appropriate for daily screening, as a first-line tool, whereas the quantitative approach should be reserved for expert ultrasound. TWEETABLE ABSTRACT This study highlights the relevance of first-trimester qualitative ultrasound signs in the screening of open spina bifida.
Collapse
Affiliation(s)
- P Mace
- Institut méditerranéen d'imagerie médicale appliquée à la gynécologie, la grossesse et l'enfance IMAGE2, Marseille, France.,Unité de dépistage et de diagnostic prénatal, Hôpital Privé Marseille Beauregard, Marseille, France
| | - J Mancini
- Public Health Department (BIOSTIC), APHM, INSERM, IRD, SESSTIM, Hop Timone, Aix Marseille Univ, Marseille, France
| | - G Gorincour
- Institut méditerranéen d'imagerie médicale appliquée à la gynécologie, la grossesse et l'enfance IMAGE2, Marseille, France.,Elsan, Clinique Bouchard, Marseille, France
| | - E Quarello
- Institut méditerranéen d'imagerie médicale appliquée à la gynécologie, la grossesse et l'enfance IMAGE2, Marseille, France.,Elsan, Clinique Bouchard, Marseille, France
| |
Collapse
|
13
|
Bendiane M, Rey D, Mancini J. 1512P Therapeutic de-escalation and decision making in early breast cancer: A radiotherapy option grid developed and implemented in France. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
14
|
Memoli V, Lailler G, Le Bihan C, Bendiane M, Lauzier S, Mancini J, Bousquet P, Bouhnik A. L’adhésion à l’hormonothérapie cinq ans après un diagnostic de cancer du sein non métastatique : une étude nationale utilisant la méthode « Group-Based Trajectory Modeling ». Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Seguin L, Touzani R, Bouhnik AD, Ben CharifF A, Marino P, Bendiane M, Gonçalves A, Gravis Mescam G, Mancini J. 1881P Deterioration of sexual health of cancer survivors 5 years after diagnosis – French national cohort VICAN. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
16
|
Breyton M, Rouquette A, Mancini J. Validation de la version française du « Cancer Information Overload » et exploration des liens avec les comportements de prévention du cancer. Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
17
|
Touzani R, Rey D, Monet A, Préau M, Bendiane M, Bouhnik A, Mancini J. Prévention tertiaire après un cancer de sein : l’enquête VICAN5. Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
18
|
Rey D, Touzani R, Monet A, Bendiane MK, Bouhnik AD, Mancini J. Physical activity and body weight of breast cancer survivors – VICAN national survey. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.1273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cancer recurrence and poor quality of life are major challenges of the growing population of breast cancer (BC) survivors. International guidelines encourage survivors to engage in regular physical activity (PA) and to maintain a healthy body weight (BW), as both have a proven benefit on survival. Our aims were (1) to describe PA and BW 5 years after a BC diagnosis and (2) to define the predictors of long-term engagement in healthy lifestyle, in a representative sample of French survivors.
Methods
The French National VICAN surveys were implemented in 2012 and 2015 among cancer survivors. This analysis focused on 723 women with BC, without progression at 5 years, and who participated in both surveys. The questionnaires dealt with several topics including socioeconomic status, treatments and side effects, psychometric scales and lifestyle habits.
Results
Five years after diagnosis, 26% of women reported regular PA, 61% occasional PA and 14% no PA. Moreover, 27% reported a weight gain ≥5kg, and 10% a weight loss ≥5kg. Half of the women had decreased or stopped PA since diagnosis. In logistic regression, long-term regular PA was associated with better mental quality of life (aOR=1.04; 1.01-1.07), no depression (aOR=3.42; 1.21-9.65), higher Post Traumatic Growth Inventory score (aOR=1.02; 1.01-1.04), normal arm mobility (aOR=3.7; 1.6-8.4) and healthy and stable BW since diagnosis (aOR=4.47; 1.61-12.37). Weight gain ≥5kg was associated with younger age (aOR=0.96; 0.93-0.99), higher BW at diagnosis (aOR=1.02; 1.01-1.04), and lymphedema 5 years after diagnosis (aOR=1.69; 1.02-2.83).
Conclusions
For BC survivors, mental well-being is essential for successful long-term investment in healthy habits. More psychological and dietary support, and a better management of sequelae are needed in this population.
Key messages
For breast cancer survivors, mental well-being is essential for successful long-term investment in healthy habits. More psychological and dietary support, and better sequelae management are needed to help breast cancer survivors to persist in healthy lifestyle.
Collapse
Affiliation(s)
- D Rey
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
| | - R Touzani
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
- SESSTIM, Institut Paoli-Calmettes, Marseille, France
| | - A Monet
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
| | - M K Bendiane
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
| | - A D Bouhnik
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
| | - J Mancini
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
- BIOSTIC, APHM, Marseille, France
| |
Collapse
|
19
|
Memoli V, Lailler G, Le-Bihan C, Bendiane MK, Lauzier S, Mancini J, Bousquet PJ, Bouhnik AD. Trajectories of adherence to adjuvant endocrine therapy for 5 years in women with breast cancer. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa166.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Adjuvant endocrine therapy (AET) is a daily oral medication prescribed for women with hormone-sensitive breast cancer (BC) to reduce recurrence and mortality risks. However, many women do not take AET daily or do not persist with AET for the recommended duration of at least 5 years. Our aims were to identify: 1) trajectories of AET adherence for the 5 years; 2) factors associated with these trajectories.
Methods
The French Cancer Cohort includes data on hospitalizations, ambulatory care and drug claims for all cancers diagnosed in France (SNDS database). Women diagnosed with a 1st non-metastatic BC in 2011 who had ≥ 1 AET claim within 12 months of surgery were included. For each woman, we estimated the monthly proportion of days covered (PDC) by an AET for 5 years after the first AET. Monthly PDCs were used to model AET adherence trajectories using group-based trajectory modeling. Statistical criteria were used to assess the suitability of the selected model. The factors associated with the trajectories were identified using multinomial logistic regressions.
Results
33,260 women were included. A 6-trajectory model was selected: 1) Stop of AET in the 1st year (6.6%), 2) Adherence for 1 year and stop (5.7%), 3) Adherence for 2.5y and stop (6.3%), 4) High adherence for 4.5y and stop (8.3%), 5) Sub-optimal adherence for 5y (4.3%), 6) Very high adherence for 5y (68.8%). Factors associated with non-adherence trajectories are mainly extreme age (>70y) and switch in AET.
Conclusions
About 70% of women had an optimal adherence for 5 years. Our results showed that women who changed AET during the treatment course were at higher risk of non-adherence. Among non-adherent women, the switch in AET is frequent and probably often related to the management of side effects. Interventions to detect and manage these side effects may help to support women with AET use. Effective management of these effects during all the 5 years could be needed to maintain adherence.
Key messages
About 70% of women had an optimal adherence for 5 years. Women who changed AET during the treatment course were at higher risk of non-adherence.
Collapse
Affiliation(s)
- V Memoli
- U1252, SESSTIM-CanBioS, Marseille, France
| | - G Lailler
- Health data and assessment department Survey, Institut National du Cancer, Boulogne Billancourt, France
| | - C Le-Bihan
- Health data and assessment department Survey, Institut National du Cancer, Boulogne Billancourt, France
| | | | - S Lauzier
- CHU de Québec-Université Laval Research Center, Axe Santé des Populations et Pratiques Optimales en Santé, Quebec, Canada
| | - J Mancini
- U1252, SESSTIM-CanBioS, Marseille, France
| | - P J Bousquet
- Health data and assessment department Survey, Institut National du Cancer, Boulogne Billancourt, France
| | - AD Bouhnik
- U1252, SESSTIM-CanBioS, Marseille, France
| |
Collapse
|
20
|
Breyton M, Smith AB, Rouquette A, Mancini J. Cancer information overload and multiple prevention behaviors. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Many people feel overwhelmed by the increasing amount of cancer-related material available in the information environment. Our aims was to evaluate the psychometric properties of the brief version of the cancer information overload (CIO) scale and to examine the association between CIO and multiple cancer prevention behaviors.
Methods
A large survey using a self-administered online questionnaire was proposed to all adult members of the Seintinelles, a French national non-profit organization. The psychometric properties of the CIO scale were evaluated. Measurement invariance across French and English languages was studied using an additional sample of 224 Australian cancer survivors from Register4. We also collected functional, communicative, and critical health literacy (FCCHL), deprivation (EPICES index), current smoking, alcohol misuse, frequent sunburns, and rare skin self-examination.
Results
Between June 16th and 30th 2016, 2 363 French participants answered the online questionnaire. The five-item CIO scale demonstrated the best balance between psychometric properties and number of items. It showed satisfactory internal consistency and adequate fit. No measurement invariance issue was found across age, gender, education level, and language groups.
CIO was increased among people with higher deprivation, lower education and a cancer information avoidant profile. In multivariate analyses, CIO was associated with tobacco use (OR = 1.05, 95%CI [1.00-1.10]), rare skin checks (OR = 1.05 [1.01-1.08]) and frequent sunburns (OR = 1.04 [1.01-1.07]), but not with alcohol misuse.
Conclusions
The 5-item CIO scale is ready to be used in French and English-speaking countries. The links observed between CIO and multiple prevention behaviors encourage further research in order to better characterize the psycho-cognitive and environmental phenomena at play. Efforts are needed to communicate adequately and empower citizens to limit the growing burden of cancer.
Key messages
The 5-item CIO scale is ready to be used in French and English-speaking countries. Efforts are needed to communicate adequately and empower citizens to limit the growing burden of cancer.
Collapse
Affiliation(s)
- M Breyton
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
- Public Health Department, APHM, Marseille, France
| | - A B Smith
- CONCERT, UNSW, Liverpool, Australia
- PoCoG, University of Sydney, Sydney, Australia
| | - A Rouquette
- Public Health and Epidemiology Department, AP-HP, Le Kremlin-Bicêtre, France
- CESP, INSERM, Univ Paris-Saclay, Univ Paris-Sud, Villejuif, France
| | - J Mancini
- SESSTIM, Aix-Marseille Univ, Inserm, IRD, Marseille, France
- Public Health Department, APHM, Marseille, France
| |
Collapse
|
21
|
Abstract
Basophils represent approximately 1% of human peripheral blood leukocytes. Their effector functions were initially appreciated in the 1970s when basophils were shown to express the high-affinity receptor (FcεRI) for IgE and to release proinflammatory mediators (histamine and cysteinyl leukotriene C4) and immunoregulatory cytokines (i.e., IL-4 and IL-13). Basophils in the mouse were subsequently identified and immunologically characterized. There are many similarities but also several differences between human and mouse basophils. Basophil-deficient mice have enabled to examine the in vivo roles of basophils in several immune disorders and, more recently, in tumor immunity. Activated human basophils release several proangiogenic molecules such as vascular endothelial growth factor-A (VEGF-A), vascular endothelial growth factor-B (VEGF-B), CXCL8, angiopoietin 1 (ANGPT1), and hepatocyte growth factor (HGF). On the other side, basophils can exert anti-tumorigenic effects by releasing granzyme B, TNF-α, and histamine. Circulating basophils have been associated with certain human hematologic (i.e., chronic myeloid leukemia) and solid tumors. Basophils have been found in tumor microenvironment (TME) of human lung adenocarcinoma and pancreatic cancer. Basophils played a role in melanoma rejection in basophil-deficient mouse model. By contrast, basophils appear to play a pro-tumorigenic role in experimental and human pancreatic cancer. In conclusion, the roles of basophils in experimental and human cancers have been little investigated and remain largely unknown. The elucidation of the roles of basophils in tumor immunity will demand studies on increasing complexity beyond those assessing basophil density and their microlocalization in TME. There are several fundamental questions to be addressed in experimental models and clinical studies before we understand whether basophils are an ally, adversary, or even innocent bystanders in cancers.
Collapse
Affiliation(s)
- Giancarlo Marone
- Department of Public Health, University of Naples Federico II, Naples, Italy
- Azienda Ospedaliera dei Colli-Monaldi Hospital Pharmacy, Naples, Italy
| | | | - Fabrizio Mattei
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| | - Jacopo Mancini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
| | - Giovanna Schiavoni
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
| | - Gilda Varricchi
- Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
- WAO Center of Excellence, Naples, Italy.
- Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy.
| |
Collapse
|
22
|
Andreone S, Spadaro F, Buccione C, Mancini J, Tinari A, Sestili P, Gambardella AR, Lucarini V, Ziccheddu G, Parolini I, Zanetti C, D’Urso MT, De Ninno A, Businaro L, Afferni C, Mattei F, Schiavoni G. IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing. Cancers (Basel) 2019; 11:cancers11111664. [PMID: 31717819 PMCID: PMC6895824 DOI: 10.3390/cancers11111664] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 10/15/2019] [Accepted: 10/21/2019] [Indexed: 12/15/2022] Open
Abstract
Eosinophils are major effectors of Th2-related pathologies, frequently found infiltrating several human cancers. We recently showed that eosinophils play an essential role in anti-tumor responses mediated by immunotherapy with the ‘alarmin’ intereukin-33 (IL-33) in melanoma mouse models. Here, we analyzed the mechanisms by which IL-33 mediates tumor infiltration and antitumor activities of eosinophils. We show that IL-33 recruits eosinophils indirectly, via stimulation of tumor cell-derived chemokines, while it activates eosinophils directly, up-regulating CD69, the adhesion molecules ICAM-1 and CD11b/CD18, and the degranulation marker CD63. In co-culture experiments with four different tumor cell lines, IL-33-activated eosinophils established large numbers of stable cell conjugates with target tumor cells, with the polarization of eosinophil effector proteins (ECP, EPX, and granzyme-B) and CD11b/CD18 to immune synapses, resulting in efficient contact-dependent degranulation and tumor cell killing. In tumor-bearing mice, IL-33 induced substantial accumulation of degranulating eosinophils within tumor necrotic areas, indicating cytotoxic activity in vivo. Blocking of CD11b/CD18 signaling significantly reduced IL-33-activated eosinophils’ binding and subsequent killing of tumor cells, indicating a crucial role for this integrin in triggering degranulation. Our findings provide novel mechanistic insights for eosinophil-mediated anti-tumoral function driven by IL-33. Treatments enabling tumor infiltration and proper activation of eosinophils may improve therapeutic response in cancer patients.
Collapse
Affiliation(s)
- Sara Andreone
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Francesca Spadaro
- Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy; (F.S.); (P.S.)
| | - Carla Buccione
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Jacopo Mancini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Antonella Tinari
- Center for Gender Medicine, Istituto Superiore di Sanità, 00161, Rome, Italy;
| | - Paola Sestili
- Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy; (F.S.); (P.S.)
| | - Adriana Rosa Gambardella
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Valeria Lucarini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Giovanna Ziccheddu
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Isabella Parolini
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Cristiana Zanetti
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Maria Teresa D’Urso
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Adele De Ninno
- Institute for Photonics and Nanotechnologies, National Research Council (CNR), 00156 Rome, Italy; (A.D.N.); (L.B.)
| | - Luca Businaro
- Institute for Photonics and Nanotechnologies, National Research Council (CNR), 00156 Rome, Italy; (A.D.N.); (L.B.)
| | - Claudia Afferni
- National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | - Fabrizio Mattei
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
| | - Giovanna Schiavoni
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy; (S.A.); (C.B.); (J.M.); (A.R.G.); (V.L.); (G.Z.); (I.P.); (C.Z.); (M.T.D.); (F.M.)
- Correspondence: ; Tel.: +39-0649906099
| |
Collapse
|
23
|
Nicollas R, Moreddu E, Le Treut-Gay C, Mancini J, Akkari M, Mondain M, Scavarda D, Hosanna G, Fayoux P, Pondaven-Letourmy S, Lescanne E, Triglia JM. Ibuprofen as risk-factor for complications of acute anterior sinusitis in children. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 137:99-103. [PMID: 31627971 DOI: 10.1016/j.anorl.2019.10.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
IMPORTANCE Non-steroidal anti-inflammatory drugs (NSAIDs) are known to inhibit chemotaxis, oxidative burst and phagocytosis, bacterial killing in granulocytes as well as inhibiting neutrophil aggregation or degranulation, thereby interfering with the function of lymphocytes. On the other hand, ibuprofen is widely prescribed in pediatrics for its powerful analgesic and antipyretic effects. To our knowledge, no previous publication outlines the relationship between Ibuprofen therapy and an increased risk of intracranial and/or orbital complications of acute fronto-ethmoidal sinusitis in childhood. OBJECTIVE To look for a relationship between ibuprofen and occurrence of intra-cranial and/or orbital complications of acute fronto-ethmoidal sinusitis in pediatrics. SETTING AND METHODS The medical charts of patients younger than 18 years admitted into the E.N.T. departments of 4 academic care centers during 2 consecutive years for fronto ethmoidal sinusitis were reviewed retrospectively. The history of ibuprofen intake, the occurrence of complication (orbital or intracranial) as well as the usual demographic data were noted. A statistical analysis was performed in order to ascertain whether a relationship between taking NSAIDs and the onset of an intracranial and/or orbital complication exists. RESULTS Intake of ibuprofen appeared to be a risk-factor of intracranial complications or associated orbital and intracranial complications of acute fronto-ethmoidal sinusitis in children. Neither gender nor age nor initial pain intensity were statistically related to the onset of complications. CONCLUSION AND RELEVANCE This retrospective multicenter cohort study appears to suggest that ibuprofen increases the risk of orbital and/or intracranial complications of acute fronto-ethmoidal sinusitis in childhood. Therefore, we recommend not prescribing ibuprofen if one suspects an acute sinusitis in a child or adolescent.
Collapse
Affiliation(s)
- R Nicollas
- Aix-Marseille University, Department of Pediatric Otolaryngology Head and Neck Surgery, La Timone Children's Hospital, 264, rue St Pierre, 13385 Marseille cedex 5, France.
| | - E Moreddu
- Aix-Marseille University, Department of Pediatric Otolaryngology Head and Neck Surgery, La Timone Children's Hospital, 264, rue St Pierre, 13385 Marseille cedex 5, France
| | - C Le Treut-Gay
- Aix-Marseille University, Department of Pediatric Otolaryngology Head and Neck Surgery, La Timone Children's Hospital, 264, rue St Pierre, 13385 Marseille cedex 5, France
| | - J Mancini
- Aix-Marseille University Department of Biostatistics and Communication and Information Technologies, BiosTIC, La Timone Hospital, Inserm, IRD, UMR912 SESSTIMF, 264, rue Saint Pierre, 13385 Marseille cedex 5, France
| | - M Akkari
- Department of Otolaryngology Head and Neck Surgery, Gui de Chauliac Hospital, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - M Mondain
- Department of Otolaryngology Head and Neck Surgery, Gui de Chauliac Hospital, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France
| | - D Scavarda
- Aix-Marseille University, Department of Pediatric Neurosurgery, La Timone Children's Hospital, 264, rue St Pierre, 13385 Marseille cedex 5, France
| | - G Hosanna
- Department of Otolaryngology Head and Neck Surgery, avenue Eugène-Avinée, 59037 Lille, France
| | - P Fayoux
- Department of Otolaryngology Head and Neck Surgery, avenue Eugène-Avinée, 59037 Lille, France
| | - S Pondaven-Letourmy
- Department of Otolaryngology Head and Neck Surgery, Gatien Clocheville Children's Hospital, 49, boulevard Béranger, 37000 Tours, France
| | - E Lescanne
- Department of Otolaryngology Head and Neck Surgery, Gatien Clocheville Children's Hospital, 49, boulevard Béranger, 37000 Tours, France
| | - J-M Triglia
- Aix-Marseille University, Department of Pediatric Otolaryngology Head and Neck Surgery, La Timone Children's Hospital, 264, rue St Pierre, 13385 Marseille cedex 5, France
| |
Collapse
|
24
|
Philip M, Tessonnier L, Mancini J, Mainardi JL, Lussato D, Cammillieri S, Weinmann P, Hagege A, Gouriet F, Camoin L, Casalta JP, Riberi A, Drancourt M, Lepidi H, Habib G. 333018F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography (PET/CT) for the diagnosis of prosthetic valve infective endocarditis (PVIE): a prospective multicenter study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0082] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and objectives
18F-FDG PET/CT has recently been added as a major criterion in the ESC 2015 infective endocarditis (IE) guidelines, but the value of this new diagnostic algorithm has never been prospectively assessed.
Purposes
1. Primary objective: to assess the value of the new ESC criteria including 18F-FDG PET/CT in prosthetic valve infective endocarditis (PVIE).
2. Secondary objectives: to determine the reproducibility of 18F-FDG PET/CT; to assess its ability to predict embolic events.
Methods
Between 2014 and 2017, 175 patients with suspected PVIE were prospectively included in 3 French centers. After exclusion of patients with uninterpretable or not feasible PET/CT,115 patients were finally included in the analysis, including 91 definite IE and 24 rejected IE, as defined by an expert Consensus of Endocarditis Team after 3-month follow-up as Gold Standard
Nuclear data were blindly analyzed by two independent nuclear medicine physicians.
Patients follow-up was scheduled at one and three months after hospitalization
Results
Significant cardiac uptake by PET/CT (major criterion) was observed in 67 among 91 patients with definite PVIE and 6 patients with rejected IE (sensitivity 73.6%, specificity 75%, positive predictive value 91%, negative predictive value 42%). Considering cardiac uptake as a major criterion, the ESC 2015 classification increased the sensitivity of Duke criteria from 57 to 84% (p<0.001) but decreased its specificity from 84 to 70% (p<0.001).
Intraobserver reproducibility of cardiac uptake evaluation was good (kappa = 0.84) but inter observer reproductibility was less satisfactory (kappa = 0.63).
Embolic events occurred in 31 patients (27%) and were correlated with vegetation size by ECHO (p<0.001), Staphylococcus infection (p=0.003), and PET/CT cardiac uptake (p=0.02).
Conclusion
1. the value of PET CT and ESC criteria is confirmed and may allow earlier diagnosis of PVIE
2. PET CT is associated with an increased risk of false positive results probably related to the technical improvements
3. Reproducibility of nuclear measurements seems unsatisfactory, justifying efforts to standardize PET studies interpretation
4. Our study describes for the first time a positive correlation between a positive PET/Ct and occurrence of embolic events, warranting additional studies.
Collapse
Affiliation(s)
- M Philip
- La Timone Hospital, Marseille, France
| | | | - J Mancini
- La Timone Hospital, Marseille, France
| | - J L Mainardi
- Hopital Europeen Georges Pompidou - University Paris Descartes, Paris, France
| | - D Lussato
- Centre Cardiologique du Nord (CCN), Paris, France
| | | | - P Weinmann
- Hopital Europeen Georges Pompidou - University Paris Descartes, Paris, France
| | - A Hagege
- Hopital Europeen Georges Pompidou - University Paris Descartes, Paris, France
| | - F Gouriet
- La Timone Hospital, Marseille, France
| | - L Camoin
- La Timone Hospital, Marseille, France
| | | | - A Riberi
- La Timone Hospital, Marseille, France
| | | | - H Lepidi
- La Timone Hospital, Marseille, France
| | - G Habib
- La Timone Hospital, Marseille, France
| |
Collapse
|
25
|
Marino P, Jalbert AC, Duran S, Mancini J, Gonçalves A, Rodwin M. The price of added value for new anti-cancer drugs in France 2004-17. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz394.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Vaillant M, Barral P, Mancini J, DeMasi M, Bal L, Piquet P. Preoperative Inferior Mesenteric Artery Embolization Is a Cost-effective Technique That May Reduce the Rate of Aneurysm Sac Diameter Enlargement and Reintervention Following EVAR. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2019.07.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Memoli V, Lailler G, Bihan-Bejamin CL, Bendiane M, Lauzier S, Mancini J, Bousquet PJ, Bouhnik AD. 5-year adherence to adjuvant endocrine therapy among women with breast cancer: A nationwide study using group-based trajectory modeling. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz262] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Mencattini A, De Ninno A, Mancini J, Businaro L, Martinelli E, Schiavoni G, Mattei F. High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications. Methods Enzymol 2019; 632:479-502. [PMID: 32000911 DOI: 10.1016/bs.mie.2019.06.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Understanding the interactions between immune and cancer cells occurring within the tumor microenvironment is a prerequisite for successful and personalized anti-cancer therapies. Microfluidic devices, coupled to advanced microscopy systems and automated analytical tools, can represent an innovative approach for high-throughput investigations on immune cell-cancer interactions. In order to study such interactions and to evaluate how therapeutic agents can affect this crosstalk, we employed two ad hoc fabricated microfluidic platforms reproducing advanced 2D or 3D tumor immune microenvironments. In the first type of chip, we confronted the capacity of tumor cells embedded in Matrigel containing one drug or Matrigel containing a combination of two drugs to attract differentially immune cells, by fluorescence microscopy analyses. In the second chip, we investigated the migratory/interaction response of naïve immune cells to danger signals emanated from tumor cells treated with an immunogenic drug, by time-lapse microscopy and automated tracking analysis. We demonstrate that microfluidic platforms and their associated high-throughput computed analyses can represent versatile and smart systems to: (i) monitor and quantify the recruitment and interactions of the immune cells with cancer in a controlled environment, (ii) evaluate the immunogenic effects of anti-cancer therapeutic agents and (iii) evaluate the immunogenic efficacy of combinatorial regimens with respect to single agents.
Collapse
Affiliation(s)
- Arianna Mencattini
- Department of Electronic Engineering, University of Rome Tor Vergata, Rome, Italy
| | - Adele De Ninno
- Institute for Photonics and Nanotechnology, Italian National Research Council, Rome, Italy; Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, Rome, Italy
| | - Jacopo Mancini
- Department of Oncology and Molecular Medicine, Tumor Immunology Unit, Istituto Superiore di Sanità, Rome, Italy
| | - Luca Businaro
- Institute for Photonics and Nanotechnology, Italian National Research Council, Rome, Italy
| | - Eugenio Martinelli
- Department of Electronic Engineering, University of Rome Tor Vergata, Rome, Italy
| | - Giovanna Schiavoni
- Department of Oncology and Molecular Medicine, Tumor Immunology Unit, Istituto Superiore di Sanità, Rome, Italy.
| | - Fabrizio Mattei
- Department of Oncology and Molecular Medicine, Tumor Immunology Unit, Istituto Superiore di Sanità, Rome, Italy.
| |
Collapse
|
29
|
Mattei F, Buccione C, Andreone S, Spadaro F, Ninno AD, Mancini J, Zanetti C, Parolini I, Iosi F, Tinari A, Lucarini V, Gerardino A, Ziccheddu G, Businaro L, Afferni C, Schiavoni G. Abstract A091: IL-33 activates antitumoral toxicity in eosinophils through stimulation of contact-dependent degranulation. Cancer Immunol Res 2019. [DOI: 10.1158/2326-6074.cricimteatiaacr18-a091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The alarmin IL-33 plays pleiotropic roles in allergy, autoimmunity and inflammation through binding to its specific receptor ST2 expressed by most hematopoietic cells. Emerging evidences suggest an involvement of this cytokine also in cancer immunity, although its function remains ill-defined. Eosinophils (EOS) are a rare blood population playing critical roles in allergic inflammation and parasitic responses. We recently showed that EOS play an essential role in anti-tumor responses against melanoma growth and pulmonary metastasis mediated by IL-33 in vivo.In the present study we analyzed the mechanisms by which IL-33 mediates tumor infiltration and antitumoral activities of EOS. We show that IL-33 indirectly stimulates the recruitment of EOS inducing tumor-derived chemokines CCL24 and CCL5. Furthermore, IL-33 directly activates EOS inducing the expression of adhesion molecules, such as the integrin CD11b, resulting in efficient contact-dependent tumor cell killing. In co-culture experiments, IL-33 activated EOS tightly bond to tumor cells, forming increased numbers of conjugates, with respect to resting eosinophils. Confocal laser-scanning microscopy (CLSM) of eosinophil-tumor cell conjugates revealed polarization of the pore-forming eosinophilic cationic protein (ECP) and of CD11b on the cell synapses exclusively in IL-33-activated, but not resting, EOS. Furthermore, we show that IL-33 activated EOS release larger amounts of extracellular vesicles (EV) with respect to resting EOS. Transmission electron microscopy (TEM) revealed increased degranulation and EV release of IL-33-activated EOS following cell contact with target tumor cells. Our results advocate for an eosinophil-mediated tumoricidal function promoted by IL-33, thus opening perspectives for novel cancer immunotherapy strategies.
Citation Format: Fabrizio Mattei, Carla Buccione, Sara Andreone, Francesca Spadaro, Adele De Ninno, Jacopo Mancini, Cristiana Zanetti, Isabella Parolini, Francesca Iosi, Antonella Tinari, Valeria Lucarini, Annamaria Gerardino, Giovanna Ziccheddu, Luca Businaro, Claudia Afferni, Giovanna Schiavoni. IL-33 activates antitumoral toxicity in eosinophils through stimulation of contact-dependent degranulation [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A091.
Collapse
Affiliation(s)
- Fabrizio Mattei
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Carla Buccione
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Sara Andreone
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Francesca Spadaro
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Adele De Ninno
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Jacopo Mancini
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Cristiana Zanetti
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Isabella Parolini
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Francesca Iosi
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Antonella Tinari
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Valeria Lucarini
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Annamaria Gerardino
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Giovanna Ziccheddu
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Luca Businaro
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Claudia Afferni
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| | - Giovanna Schiavoni
- Istituto Supreiore di Sanità, Rome, Italy; "Bambino Gesù" Pediatric Hospital, Rome, Italy; Institute for Photonics and Nanotechnologies, National Research Council, Rome, Italy
| |
Collapse
|
30
|
Riviere D, Mancini J, Santini L, Loth Bouketala A, Giovanni A, Dessi P, Fakhry N. Nodal metastases distribution in laryngeal cancer requiring total laryngectomy: Therapeutic implications for the N0 Neck. Eur Ann Otorhinolaryngol Head Neck Dis 2018; 136:S35-S38. [PMID: 30174259 DOI: 10.1016/j.anorl.2018.08.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2018] [Revised: 08/09/2018] [Accepted: 08/15/2018] [Indexed: 10/28/2022]
Abstract
OBJECTIVES Neck dissection is a controversial surgical procedure in patients with squamous cell carcinoma of the Larynx free of any node metastasis detected in preoperative staging. The aim of this study was to investigate the distributions of lymph node metastases in laryngeal squamous cell carcinoma and improve the rationale for elective treatment of N0 neck. MATERIAL AND METHODS Retrospective single-center series of Seventy-eight successive patients with laryngeal squamous cell carcinoma who underwent neck dissection between 2008 and 2015. RESULTS Surgery was first-line treatment in 37 patients (47%) and for recurrent disease in 41 (53%). The rate of occult nodal metastasis was 14% (n=11): levels IIa and/or III were affected in 9 cases (11.5%) compared with single cases of IIb and IV involvement (1.3% each). The rate of occult nodal metastasis was significantly lower among patients operated on for recurrent disease after radiotherapy than in patients who never had any radiotherapy of the cervical lymph nodes (0% vs. 16.7%, P=0.03). CONCLUSIONS Selective cervical lymph node dissection in levels IIa and III sparing levels IIb and IV seems to be ideal in total laryngectomy in patients with cN0 laryngeal squamous cell carcinoma. Omitting lymph node dissection altogether may be considered in total laryngectomy on a cN0 patient showing recurrence after radiotherapy.
Collapse
Affiliation(s)
- D Riviere
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France; École du Val-de-Grâce, 75005 Paris, France
| | - J Mancini
- UMR912, IRD, SESSTIM, 13005 Marseille, France; Inserm, UMR912, SESSTIM, 13005 Marseille, France; BiosTIC, hôpital de la Timone, Assistance publique des hôpitaux de Marseille (AP-HM), 13005 Marseille, France
| | - L Santini
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France
| | - A Loth Bouketala
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France
| | - A Giovanni
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France
| | - P Dessi
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France
| | - N Fakhry
- Service d'ORL et de chirurgie cervico-faciale, centre hospitalier universitaire de la conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France.
| |
Collapse
|
31
|
Serin D, Adnot S, Allioux C, Alran S, Bazin B, Bendiane MK, Bo-Gallon E, Boinon D, Bouhnik AD, Bourstyn E, Charles C, Clément A, Coussirou J, Cutuli B, Dauchy S, Debourdeau P, Degos L, Duponchel P, Durand T, Eisinger F, Falandry C, Favier B, Heudel P, Ledig C, Lesur A, Mancini J, Monet A, Moretta J, Neveu J, Ninot G, Préau M, Ravot C, Rousset-Jablonski C, Touzani R, Valéro M, Zambrowski JJ. SFSPM 2018 — Congrès de la Société Française de Sénologie et de Pathologie Mammaire (Avignon, 7-9/11-2018). ONCOLOGIE 2018. [DOI: 10.3166/onco-2019-0040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Les 40es Journées de la SFSPM se sont tenues à Avignon du 7 au 9 novembre 2018. Le thème abordé—Cancer du sein : optimisation du parcours de soins — a réuni plus de 1 200 participants sous les voûtes du Palais des Papes. La fluidité de chaque segment du parcours a été analysée en termes de risques de rupture de continuité des soins tant au sein du segment lui-même qu’en amont et en aval. Dans un parcours par essence pluridisciplinaire et plurimétiers, la nécessité d’une réflexion globale et d’une coordination active réalisées par des professionnels formés a été rappelée à chaque session. Chacun des intervenants a esquissé de potentiels indicateurs de qualité tenant compte à la fois de son implication dans son segment d’intervention, mais tenant compte aussi d’une vision plus globale de ce que devrait être le parcours au travers de la maladie et des soins. La parole a été très largement partagée entre soignants et associations de malades, entre paramédicaux et acteurs en sciences humaines et sociales, entre responsables de la santé publique HAS, ARS, CNAM–CPAM 84 et représentants des différents modes d’hospitalisation publique/privée et ESPIC. La session grand public a été l’occasion d’échanges fructueux et instructifs sur la perception des difficultés comme des satisfactions rencontrées que nous ont fait partager les malades, leurs proches et les représentantes des associations. Au total, un congrès de réflexion partagé par de nombreux acteurs qui cherchent tous à améliorer le parcours de soins des malades atteintes de cancer du sein. La publication le 21 janvier par l’INCa de dix indicateurs de qualité du parcours de soins pour les malades atteints de cancer du sein est une étape importante qu’attendaient tous les participants d’Avignon — SFSPM 2018.
Collapse
|
32
|
Rivière D, Mancini J, Santini L, Giovanni A, Dessi P, Fakhry N. Lymph-node metastasis following total laryngectomy and total pharyngolaryngectomy for laryngeal and hypopharyngeal squamous cell carcinoma: Frequency, distribution and risk factors. Eur Ann Otorhinolaryngol Head Neck Dis 2018; 135:163-166. [DOI: 10.1016/j.anorl.2017.11.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Touzani R, Bendiane MK, Bouhnik AD, Bruneau L, Mancini J, Chirpaz E, Huiart L. Connaissances sur le dépistage et le cancer du col de l’utérus à la Réunion : application d’une classification ascendante hiérarchique. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.03.320] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
34
|
Bouhnik AD, N’Diaye K, Evans G, Harris H, Tibben A, van Asperen C, Schmidtke J, Nippert I, Mancini J, Julian-Reynier C. Validation d’une échelle sur l’évaluation des effets positifs et négatifs des tests génétiques chez les médecins français dans le contexte BRCA1/2. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.03.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
35
|
Rajae T, Bendiane M, Chirpaz E, Bouhnik A, Bruneau L, Mancini J, Huiart L. Mammography screening among women living in Reunion Island (South Indian Ocean). Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30499-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
36
|
Bendiane M, Bouhnik A, Monet A, Mancini J, Peretti-Watel P. Over-declaration of Pap Smear test use among the French five-years breast cancer survivors: Results from the VICAN5 survey. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30494-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Radulesco T, Mancini J, Penicaud M, Dessi P, Michel J. Assessing normal values for the FACE-Q rhinoplasty module: An observational study. Clin Otolaryngol 2018; 43:1025-1030. [PMID: 29451357 DOI: 10.1111/coa.13086] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/12/2018] [Indexed: 11/28/2022]
Abstract
OBJECTIVES The goal of this study was to determine normal values for the FACE-Q rhinoplasty module. DESIGN A prospective monocentric observational cohort study. SETTING We tested FACE-Q Satisfaction with Nose and Satisfaction with Nostrils in two groups of patients, seeking or not a rhinoplasty. PARTICIPANTS One hundred and four patients were included in the study, fifty-two in each group. MAIN OUTCOME MEASUREMENTS Primary outcome was to identify possible cutting scores to establish normal values for each of the FQRM questionnaires. RESULTS Regarding the Satisfaction with Nose scale, there was a statistically significant difference between the two groups (P < .001). Area under the ROC curve was 0.964 (95% CI = 0.931-0.997). Forty-seven points was the value presenting the best Youden index (sensitivity = 96.2%, specificity = 86.5%). Regarding the Satisfaction with Nostrils scale, there was a statistically significant difference between the two groups (P < .001). Area under the ROC curve was 0.820 (95% CI = 0.741-0.899). Sixty-four points was the value presenting the best Youden index (sensitivity = 94.2%, specificity = 53.8%). CONCLUSION This is the first study to generate normative data for the FACE-Q rhinoplasty module. The findings presented here have important implications for future clinical care and research. The definition of a normal score can help practitioners to better analyse their patients and to support a therapeutic indication.
Collapse
Affiliation(s)
- T Radulesco
- Department of Oto-Rhino-Laryngology and Head and Neck Surgery, La Conception University Hospital, APHM, Marseille, France.,CNRS, IUSTI, Aix Marseille University, Marseille, France
| | - J Mancini
- Public Health Department (BIOSTIC), La Timone University Hospital, APHM, Marseille, France.,Inserm, IRD, Aix-Marseille University, Marseille, France
| | - M Penicaud
- Department of Oto-Rhino-Laryngology and Head and Neck Surgery, La Conception University Hospital, APHM, Marseille, France
| | - P Dessi
- Department of Oto-Rhino-Laryngology and Head and Neck Surgery, La Conception University Hospital, APHM, Marseille, France.,CNRS, IUSTI, Aix Marseille University, Marseille, France
| | - J Michel
- Department of Oto-Rhino-Laryngology and Head and Neck Surgery, La Conception University Hospital, APHM, Marseille, France.,CNRS, IUSTI, Aix Marseille University, Marseille, France
| |
Collapse
|
38
|
Kerzoncuf M, Jaouen M, Mancini J, Delarque A, Bensoussan L, Viton JM. Satisfaction and long-term use of orthopedic shoes in people with chronic stroke. Ann Phys Rehabil Med 2018; 61:180-182. [PMID: 29476932 DOI: 10.1016/j.rehab.2018.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Revised: 02/07/2018] [Accepted: 02/09/2018] [Indexed: 11/25/2022]
Affiliation(s)
- M Kerzoncuf
- Aix Marseille Univ, APHM, INT, Inst Neurosci Timone, CHU Timone, Physical and Rehabilitation Medicine Department, 13005 Marseille, France.
| | - M Jaouen
- Aix Marseille Univ, APHM, CHU Timone, Physical and Rehabilitation Medicine Department, 13005 Marseille, France
| | - J Mancini
- Aix Marseille Université, Inserm, IRD, 13005 Marseille, France
| | - A Delarque
- Aix Marseille Univ, APHM, INT, Inst Neurosci Timone, CHU Timone, Physical and Rehabilitation Medicine Department, 13005 Marseille, France
| | - L Bensoussan
- Aix Marseille Univ, APHM, INT, Inst Neurosci Timone, CHU Timone, Physical and Rehabilitation Medicine Department, 13005 Marseille, France
| | - J-M Viton
- Aix Marseille Univ, APHM, INT, Inst Neurosci Timone, CHU Timone, Physical and Rehabilitation Medicine Department, 13005 Marseille, France
| |
Collapse
|
39
|
Carballeira Álvarez A, Mancini J, Tuchtan-Torrents L, Gach P, Bartoli C, Desfeux J, Piercecchi MD, Gorincour G. Diagnostic value of unenhanced postmortem computed tomography in the detection of traumatic abdominal injuries. Diagn Interv Imaging 2018; 99:397-402. [PMID: 29475777 DOI: 10.1016/j.diii.2017.12.015] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Revised: 12/26/2017] [Accepted: 12/30/2017] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To determine the diagnostic capabilities of unenhanced postmortem computed tomography (UPMCT) in detecting traumatic abdominal injuries. MATERIAL AND METHODS Cases of traumatic death with both UPMCT and classical autopsy were collected retrospectively from our institution "virtopsy" database in a period of 5 years. Cadavers with gunshot injuries were excluded. Sensitivity, specificity, accuracy, negative (NPV) and positive (PPV) predictive values of PMCT globally and for hemoperitoneum, liver, spleen, pancreas and kidney injuries individually were estimated using the autopsy report as gold standard. RESULTS Seventy-one cadavers were included. UPMCT had a sensitivity of 80% and a specificity 94%, with an accuracy of 83%, a PPV of 98% and a NPV of 59% for the diagnosis of traumatic abdominal injuries. The highest sensitivity was obtained for the detection of hepatic injuries (71%) and the lowest for pancreatic injuries (12%). UPMCT had a specificity of 100% for the detection of hemoperitoneum. A NPV of 98% was found for the detection of perihepatic hematomas. CONCLUSION The low sensitivity and low NPV do not support the use of UPMCT as an alternative to conventional autopsy to diagnose and/or rule out traumatic abdominal injuries. Nevertheless, UPMCT remains a helpful tool as it helps detect hemoperitoneum and virtually exclude presence of perihepatic hematomas.
Collapse
Affiliation(s)
- A Carballeira Álvarez
- Department of Radiology, Donostia Hospital (Osakidetza), P° Doctor Beguiristain, s/n, 20014 San Sebastián, Spain.
| | - J Mancini
- Inserm, IRD, UMR912 SESSTIM, Aix-Marseille université, 105, 27, boulevard Leï Roure, CS 30059, 13273 Marseille cedex 09, France; Public Health Department (BIOSTIC), Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - L Tuchtan-Torrents
- Department of Forensic Medicine, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - P Gach
- Department of Medical Imaging, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - C Bartoli
- Department of Forensic Medicine, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - J Desfeux
- Department of Forensic Medicine, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - M D Piercecchi
- Department of Forensic Medicine, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| | - G Gorincour
- Department of Medical Imaging, Timone hospital (APHM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France
| |
Collapse
|
40
|
Raskin A, Ruquet M, Weiss-Pelletier L, Mancini J, Boulogne O, Michel J, Fakhry N, Foletti JM, Chossegros C, Giorgi R. Upper aerodigestive tract cancer and oral health status before radiotherapy: A cross-sectional study of 154 patients. J Stomatol Oral Maxillofac Surg 2017; 119:2-7. [PMID: 28911982 DOI: 10.1016/j.jormas.2017.09.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2017] [Accepted: 09/04/2017] [Indexed: 11/26/2022]
Abstract
OBJECTIVES We aimed to determine primarily the oral health status of patients with upper aerodigestive tract cancer before radiotherapy, and secondarily the prevalence of risk factors for poor oral status. METHODS A cross-sectional study was conducted in Marseille University hospital. Assessment criteria were the Decay, Missing and Filled (DMF) Index and periodontal status. RESULTS One hundred and fifty-four patients, mean age 60.9years, were included. The most common sites of primary tumors were the larynx (28.6%) and oral cavity (26.6%). Current or past smokers accounted for 80.5% of patients and 67% were alcohol abusers. Most patients (83.8%) did not have xerostomia. They ate three meals a day (61%), with sugar consumption in 40%. The median number of daily tooth brushings was 2, with a manual toothbrush (81.2%). Few patients used dental floss or interproximal brushes. Individual DMF index was 17.6 (D=2.3, M=9.3, F=6.0) and was higher in patients with xerostomia and alcohol abusers (P=0.01). Osseous level was 62.3% and 57.8% of patients had osseous infections, which were more common with poor hygiene (P=0.04). Most patients (85.7%) had periodontal disease, but incidence did not significantly differ according to risk factors. DISCUSSION The DMF index was higher in presence of periodontal disease and osseous infections. Alcohol and xerostomia were associated with a high individual DMF index and osseous infections were more frequent in patients with poor hygiene. Patients with upper aerodigestive tract cancer are at high risk of osteoradionecrosis if they do not receive dental treatment before radiotherapy.
Collapse
Affiliation(s)
- A Raskin
- Faculté d'odontologie, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle d'odontologie, UF des soins spécifiques, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France; EFS CNRS, faculté de médecine, UMR 7268 ADES, Aix-Marseille université, 51, boulevard Pierre-Dramard, 13944 Marseille cedex 15, France.
| | - M Ruquet
- Faculté d'odontologie, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle d'odontologie, UF des soins spécifiques, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France; EFS CNRS, faculté de médecine, UMR 7268 ADES, Aix-Marseille université, 51, boulevard Pierre-Dramard, 13944 Marseille cedex 15, France
| | - L Weiss-Pelletier
- Pôle d'odontologie, UF des soins spécifiques, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| | - J Mancini
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle de santé publique BIOSTIC, service biostatistique et technologies de l'information et de la communication, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France; SESSTIM sciences économiques et sociales de la santé et traitement de l'information médicale, UMR 912 Inserm/IRD/Aix-Marseille université, faculté de médecine, 27, boulevard Jean-Moulin, 13385 Marseille cedex 5, France
| | - O Boulogne
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle de santé publique BIOSTIC, service biostatistique et technologies de l'information et de la communication, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France; SESSTIM sciences économiques et sociales de la santé et traitement de l'information médicale, UMR 912 Inserm/IRD/Aix-Marseille université, faculté de médecine, 27, boulevard Jean-Moulin, 13385 Marseille cedex 5, France
| | - J Michel
- EFS CNRS, faculté de médecine, UMR 7268 ADES, Aix-Marseille université, 51, boulevard Pierre-Dramard, 13944 Marseille cedex 15, France; Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle PROMO, service ORL et chirurgie cervico-faciale, hôpital de la conception, Assistance publique-Hôpitaux de Marseille, 147, boulevard Baille, 13005 Marseille, France
| | - N Fakhry
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle PROMO, service ORL et chirurgie cervico-faciale, hôpital de la conception, Assistance publique-Hôpitaux de Marseille, 147, boulevard Baille, 13005 Marseille, France
| | - J M Foletti
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France
| | - C Chossegros
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle PROMO, service ORL et chirurgie cervico-faciale, hôpital de la conception, Assistance publique-Hôpitaux de Marseille, 147, boulevard Baille, 13005 Marseille, France
| | - R Giorgi
- Faculté de médecine, Aix-Marseille université, 27, boulevard Jean-Moulin, 13355 Marseille cedex 5, France; Pôle de santé publique BIOSTIC, service biostatistique et technologies de l'information et de la communication, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France; SESSTIM sciences économiques et sociales de la santé et traitement de l'information médicale, UMR 912 Inserm/IRD/Aix-Marseille université, faculté de médecine, 27, boulevard Jean-Moulin, 13385 Marseille cedex 5, France
| |
Collapse
|
41
|
Meurer M, Duffaud F, Salas S, Bertucci F, Floquet A, Penel N, Ray-Coquard I, Italiano A, Blay JY, Pautier P, Delannes M, Piperno-Neumann S, Mancini J, Auriche M. Localized undifferentiated endometrial sarcomas (LUES): Results of a French Sarcoma Group (FSG) retrospective series of 39 patients (pts). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx387.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Montava M, Rossi V, CurtoFais CL, Mancini J, Lavieille JP. Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life. Acta Otorhinolaryngol Ital 2017; 36:220-7. [PMID: 27214834 PMCID: PMC4977010 DOI: 10.14639/0392-100x-899] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/28/2015] [Accepted: 12/02/2015] [Indexed: 12/05/2022]
Abstract
Hemifacial spasm is a condition that may severely reduce patients' quality of life. Microvascular decompression is the neurosurgical treatment of choice. The objective of this work was to describe the efficacy and morbidity of microvascular decompression for hemifacial spasm, evaluate the long-term efficacy on the quality of life and investigate prognostic factors for failure of the procedure. A retrospective study of 446 cases of hemifacial spasm treated by 511 retrosigmoid microvascular decompression over 22 years was conducted. Epidemiological, clinical and imaging findings, treatment modalities and outcomes of patients with pre- and postoperative HSF-8 quality of life questionnaire were studied. Success rate was 82% after first surgery and 91.6% after revision surgery. A low rate of perioperative morbidity was found. Facial palsy was mostly transient (5.5% transient and 0.2% permanent) and cochleovestibular deficit was seen in 4.8% of patients. Revision surgery increased nervous lesions (10.6% to 20.7%). Mean quality of life scores were significantly improved from 18 to 2 over 32, evaluated 7.3 years after surgery. Predictive factors of surgical failure were single conflicts (p = 0.041), atypical vasculo-nervous conflicts involving other vessel than postero-inferior cerebellar artery (p = 0.036), such as vein (p = 0.045), and other compression sites than root exit zone (p = 0.027). Retrosigmoid microvascular decompression is a safe and effective treatment of hemifacial spasm. Revision surgery is not to be excluded in case of failure, but does place patients at risk for more complications. Quality of life is improved in the long-term, indicating objective and subjective satisfaction.
Collapse
Affiliation(s)
- M Montava
- Aix Marseille Université, IFSSTA R, LBA, UMR-T 24, Marseille, France;,APHM, Hôpital de la Conception, Service d'Oto-rhino-laryngologie et de Chirurgie cervico-faciale, Marseille, France
| | - V Rossi
- APHM, Hôpital de la Conception, Service d'Oto-rhino-laryngologie et de Chirurgie cervico-faciale, Marseille, France
| | - C L CurtoFais
- Hôpital Saint Musse, Service d'Otorhino- laryngologie et de Chirurgie cervico-faciale, Toulon, France
| | - J Mancini
- Aix Marseille Université, INSERM, IRD, UMR912 SESSTIM, Marseille, France;,APHM, Hôpital de la Timone, BiosTIC, Service Biostatistique et Technologies de l'Information et de la Communication, Marseille, France
| | - J-P Lavieille
- Aix Marseille Université, IFSSTA R, LBA, UMR-T 24, Marseille, France;,APHM, Hôpital de la Conception, Service d'Oto-rhino-laryngologie et de Chirurgie cervico-faciale, Marseille, France
| |
Collapse
|
43
|
Michel J, Radulesco T, Penicaud M, Mancini J, Dessi P. Sinonasal adenocarcinoma: clinical outcomes and predictive factors. Int J Oral Maxillofac Surg 2017; 46:422-427. [DOI: 10.1016/j.ijom.2016.11.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2016] [Revised: 11/30/2016] [Accepted: 11/30/2016] [Indexed: 11/28/2022]
|
44
|
Ousseine Y, Butow P, Fenaux P, Dring R, Festy P, Vey N, Mancini J. Psychological Distress Among MDS Patients: Prevalence and Correlates. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30337-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
45
|
Michel J, Radulesco T, Mancini J, Paganelli A, Varoquaux A, Adalian P, Ranque S, Dessi P. Maxillary sinus volume: new physiopathological data in fungal ball genesis? A retrospective study. Clin Otolaryngol 2017; 42:831-836. [PMID: 28004496 DOI: 10.1111/coa.12813] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/19/2016] [Indexed: 11/29/2022]
Abstract
OBJECTIVES The goal of this study was to compare maxillary sinus (MS) volume in patients with, or without, maxillary fungal ball. DESIGN Monocentric retrospective study performed on 115 patient CT scans. SETTINGS We defined two groups of patients according to the absence (control group) or the presence (fungal ball group) of unilateral fungal ball in the MS. Sinus 3D reconstruction was created from CT scan. PARTICIPANTS Control group: 71 patients (36 women - 50.7%); mean age was 51 years. Fungal ball group: 44 patients (29 women - 65.9%); mean age was 54.5 years. MAIN OUTCOME MEASURE The univariate association between MS volume and sinus covariates was tested by anova. Multivariate analysis was made including all variables statistically significant in univariate analysis. RESULTS In the control group, mean MS volume was 14 766 mm3 . The volumes of the two MSs were not statistically different in the control group (P = 0.145). In the fungal ball group, mean MS volume was 15 982 mm3 . Fungal ball was found in the smallest MS in 41 of 44 cases. Univariate analysis showed a statistical difference between the pathological and the non-pathological MS volumes (P < 10-4 ). Multivariate analysis confirmed the correlation between MS volume and the presence of a fungal ball (P < 10-4 ). CONCLUSIONS This study suggests that maxillary fungal ball is associated with a smaller size of the affected MS.
Collapse
Affiliation(s)
- J Michel
- Department of Otorhinolaryngology, Head and Neck Surgery, APHM CHU La Conception, Marseille, France.,UMR 7268 ADES - Aix-Marseille University/EFS/CNRS, Marseille, France
| | - T Radulesco
- Department of Otorhinolaryngology, Head and Neck Surgery, APHM CHU La Conception, Marseille, France.,UMR 7268 ADES - Aix-Marseille University/EFS/CNRS, Marseille, France
| | - J Mancini
- Department of Public Health and Medical Information, APHM CHU La Timone and Aix-Marseille University, Marseille, France
| | - A Paganelli
- Department of Otorhinolaryngology, Head and Neck Surgery, APHM CHU La Conception, Marseille, France.,UMR 7268 ADES - Aix-Marseille University/EFS/CNRS, Marseille, France
| | - A Varoquaux
- Department of Radiology, APHM CHU La Timone, Marseille, France
| | - P Adalian
- UMR 7268 ADES - Aix-Marseille University/EFS/CNRS, Marseille, France
| | - S Ranque
- Parasitologie-Mycologie, APHM CHU La Timone and Aix-Marseille University, Marseille, France.,IP-TPT UMR MD3, Aix-Marseille University, Marseilles, France
| | - P Dessi
- Department of Otorhinolaryngology, Head and Neck Surgery, APHM CHU La Conception, Marseille, France.,UMR 7268 ADES - Aix-Marseille University/EFS/CNRS, Marseille, France
| |
Collapse
|
46
|
Cluzol L, Cautela J, Michelet P, Roch A, Kerbaul F, Mancini J, Laine M, Peyrol M, Robin F, Bonello L, Paganelli F, Thuny F. Pre- and in-hospital course of care for patients with acute heart failure: features and impact on prognosis in the real life. Archives of Cardiovascular Diseases Supplements 2017. [DOI: 10.1016/s1878-6480(17)30141-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Arnoux V, Carsin A, Bosdure E, Retornaz K, Chabrol B, Gorincour G, Mancini J, Dabadie A, Dubus JC. Radiographie de thorax et bronchiolite aiguë : des indications en diminution ? Arch Pediatr 2017; 24:10-16. [DOI: 10.1016/j.arcped.2016.10.016] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2016] [Revised: 09/23/2016] [Accepted: 10/21/2016] [Indexed: 11/29/2022]
|
48
|
Hamouda S, Mancini J, Marchand F, Bretelle F, Boubli L, D’Ercole C, Carcopino X. Severe perineal morbidity of instrumental deliveries using Thierry's spatulas and vacuum extraction: A prospective observational cohort study. J Gynecol Obstet Hum Reprod 2017; 46:43-51. [DOI: 10.1016/j.jgyn.2015.11.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Revised: 10/25/2015] [Accepted: 11/04/2015] [Indexed: 11/24/2022]
|
49
|
Quarello E, Lacoste R, Mancini J, Melot–Dusseau S, Gorincour G. ShearWave elastography of fetal lungs in pregnant baboons. Diagn Interv Imaging 2016; 97:605-10. [DOI: 10.1016/j.diii.2015.11.019] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2015] [Accepted: 11/23/2015] [Indexed: 10/21/2022]
|
50
|
Lorcy S, Gaudy-Marqueste C, Botta D, Portal I, Quiles N, Oulies V, Mancini J, Grob JJ, Richard MA. [Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study]. Ann Dermatol Venereol 2016; 143:336-46. [PMID: 27161648 DOI: 10.1016/j.annder.2016.02.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2015] [Revised: 01/25/2016] [Accepted: 02/10/2016] [Indexed: 01/14/2023]
Abstract
BACKGROUND Telaprevir, sale of which was suspended, has been approved in combination with pegylated interferon and ribavirin (triple therapy) in the treatment of chronic hepatitis C virus (HCV). Skin eruptions and isolated cases of severe cutaneous adverse reactions (SCAR) have been reported. AIMS Our aim was to assess the incidence of skin eruption and the clinical characteristics of mucocutaneous adverse events (AE), and to identify potential risk factors for telaprevir-associated skin eruption. PATIENTS AND METHODS A prospective observational multicenter follow-up cohort study with monthly controls by a dermatologist and additional examinations in case of any undercurrent AE. RESULTS Among the 48 enrolled patients, the incidence of skin eruption was 58.4%, consisting mainly of maculopapular and eczematous lesions and only one case of SCAR. Telaprevir was discontinued in 6% of patients due to severe rash, whereas peginterferon and ribavirin were continued. The median time to onset of rash following telaprevir initiation was 25 days (range: 3-79 days). The rash was preceded by skin dryness and associated with pruritus in 100% and 90% of patients, respectively. Of those presenting with skin eruption, 37.5% also complained of conjunctival or oral lesions, or of anorectal symptoms. Neither a past history of dermatological conditions nor sociodemographic or viral status was predictive factor for skin rash. CONCLUSIONS Telaprevir-related dermatitis has a high incidence but is mostly of mild intensity. In most cases, tri-therapy was continued under close dermatological follow-up allowing rapid detection of rare instances of severe drug eruptions. Ribavirin and Interferon were thus continued even in the event of diffuse eruptions, enabling confirmation of the causative role of telaprevir in these eruptions.
Collapse
Affiliation(s)
- S Lorcy
- Inserm CRO2, UMR 911, service de dermatologie et de cancérologie cutanée, hôpital de la Timone, Aix-Marseille université, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| | - C Gaudy-Marqueste
- Inserm CRO2, UMR 911, service de dermatologie et de cancérologie cutanée, hôpital de la Timone, Aix-Marseille université, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France.
| | - D Botta
- Service d'hépato-gastroentérologie, hôpital Conception, Aix-Marseille université, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - I Portal
- Service d'hépato-gastroentérologie, hôpital Conception, Aix-Marseille université, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - N Quiles
- Service de dermatologie, hôpital Saint-Joseph, 26, boulevard de Louvain, 13285 Marseille, France
| | - V Oulies
- Service d'hépato-gastroentérologie, hôpital Saint-Joseph, 26, boulevard de Louvain, 13285 Marseille, France
| | - J Mancini
- Inserm, IRD, SESSTIM, service de santé publique et d'information médicale, hôpital de la Timone, Aix-Marseille université, AP-HM, 13385 Marseille, France
| | - J-J Grob
- Inserm CRO2, UMR 911, service de dermatologie et de cancérologie cutanée, hôpital de la Timone, Aix-Marseille université, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| | - M-A Richard
- Inserm CRO2, UMR 911, service de dermatologie et de cancérologie cutanée, hôpital de la Timone, Aix-Marseille université, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| |
Collapse
|